Sweden Biotechnology & Medical Research

Xintela AB (XINT)

Track

Track

Xintela AB experienced significant insider buying activity in early December 2025. Multiple executives and board members, including Thomas Eldered and CEO Evy Lundgren Åkerlund, acquired substantial equity stakes. These transactions represent the most recent market participation by company leadership, occurring well over three months ago.
Ticker: XINT Exchange: STO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Xintela AB. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.7
Thomas Eldered Member of the Board of Directors Director
Transaction date
Purchase
Price
212.63
Quantity 49,096
Value SEK1,069,000
1.7
Thomas Eldered Member of the Board of Directors Director
Through Flerie Invest AB, a closely affiliated person
Transaction date
Purchase
Price
71.72
Quantity 25,441
Value SEK2,400,326
3.2
DEREK BATCHELLER Chairman of the Board of Directors Director
Transaction date
Purchase
Price
74.71
Quantity 55,505
Value SEK165,332
2.8
Lars Hedbys Member of the Board of Directors Director
Transaction date
Purchase
Price
0.26
Quantity 260,000
Value SEK67,600
1.8
Lars-Peter Ekolind Deputy CEO/Deputy Managing Director Officer
Through Pekoli AB, a closely affiliated person
Transaction date
Purchase
Price
0.26
Quantity 211,120
Value SEK54,891
3.7
Gunnar Telhammar Chief Financial Officer (CFO) Officer
Transaction date
Purchase
Price
0.26
Quantity 206,820
Value SEK53,773
2.8
Evy Lundgren Åkerlund Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
0.26
Quantity 400,000
Value SEK104,000
3.7
Gunnar Telhammar Chief Financial Officer (CFO) Officer
Transaction date
Purchase
Price
0.24
Quantity 483,328
Value SEK115,999
0.6
BioFinans AB Chief Financial Officer (CFO) Officer
Through a closely affiliated person
Transaction date
Sale
Price
0.24
Quantity 483,328
Value SEK115,999
Lucienne Angela Vonk Other member of the company's administrative, management or supervisory body
Transaction date
Purchase
Price
0.02
Quantity 927,581
Value SEK15,769
3.2
DEREK BATCHELLER Chairman of the Board of Directors Director
Transaction date
Purchase
Price
0.02
Quantity 927,581
Value SEK15,769
Liselotte Theorell Other member of the company's administrative, management or supervisory body
Transaction date
Purchase
Price
0.02
Quantity 927,581
Value SEK15,769
Camilla Wennersten Other member of the company's administrative, management or supervisory body
Transaction date
Purchase
Price
0.02
Quantity 927,581
Value SEK15,769
3.7
Gunnar Telhammar Chief Financial Officer (CFO) Officer
Through BioFinans AB, a closely affiliated person
Transaction date
Purchase
Price
0.02
Quantity 927,581
Value SEK15,769
2.8
Evy Lundgren Åkerlund Chief Executive Officer (CEO)/Managing Directory Officer
Transaction date
Purchase
Price
0.02
Quantity 13,300,465
Value SEK252,709
1.0
Maarten de Chateau Member of the Board of Directors Director
Transaction date
Purchase
Price
0.90
Quantity 42,000
Value SEK37,800
Evy Lundgren-Åkerlund Chief Executive Officer (CEO)/Managing Directory Officer
Through Anders Åkerlund, a closely affiliated person
Transaction date
Purchase
Price
0.90
Quantity 192,000
Value SEK172,800
Peter Ekolind Other senior executive Officer
Through Pekoli AB, a closely affiliated person
Transaction date
Purchase
Price
0.90
Quantity 177,776
Value SEK159,998
3.2
DEREK BATCHELLER Chairman of the Board of Directors Director
Transaction date
Purchase
Price
0.90
Quantity 839,244
Value SEK755,320
3.7
Gunnar Telhammar Chief Financial Officer (CFO) Officer
Transaction date
Purchase
Price
0.90
Quantity 6,000
Value SEK5,400
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-09 2025-12-09 B Purchase
1.7
Thomas Eldered

Member of the Board of Directors

Director
49,096
212.63
SEK1,069,000 		49,096 212.63 SEK1,069,000
2025-12-09 2025-12-05 B Purchase
1.7
Thomas Eldered

Member of the Board of Directors

Through Flerie Invest AB, a closely affiliated person Director
25,441
71.72
SEK2,400,326 		25,441 71.72 SEK2,400,326
2025-12-08 2025-12-05 B Purchase
3.2
DEREK BATCHELLER

Chairman of the Board of Directors

Director
55,505
74.71
SEK165,332 		55,505 74.71 SEK165,332
2025-12-08 2025-12-05 B Purchase
2.8
Lars Hedbys

Member of the Board of Directors

Director
260,000
0.26
SEK67,600 		260,000 0.26 SEK67,600
2025-12-07 2025-12-05 B Purchase
1.8
Lars-Peter Ekolind

Deputy CEO/Deputy Managing Director

Through Pekoli AB, a closely affiliated person Officer
211,120
0.26
SEK54,891 		211,120 0.26 SEK54,891
2025-12-06 2025-12-05 B Purchase
3.7
Gunnar Telhammar

Chief Financial Officer (CFO)

Officer
206,820
0.26
SEK53,773 		206,820 0.26 SEK53,773
2025-12-07 2025-12-03 B Purchase
2.8
Evy Lundgren Åkerlund

Chief Executive Officer (CEO)/Managing Directory

Officer
400,000
0.26
SEK104,000 		400,000 0.26 SEK104,000
2024-03-20 2024-03-19 B Purchase
3.7
Gunnar Telhammar

Chief Financial Officer (CFO)

Officer
483,328
0.24
SEK115,999 		483,328 0.24 SEK115,999
2024-03-20 2024-03-19 S Sale
0.6
BioFinans AB

Chief Financial Officer (CFO)

Through a closely affiliated person Officer
483,328
0.24
SEK115,999 		483,328 0.24 SEK115,999
2023-12-04 2023-11-27 B Purchase
Lucienne Angela Vonk

Other member of the company's administrative, management or supervisory body
927,581
0.02
SEK15,769 		927,581 0.02 SEK15,769
2023-11-30 2023-11-27 B Purchase
3.2
DEREK BATCHELLER

Chairman of the Board of Directors

Director
927,581
0.02
SEK15,769 		927,581 0.02 SEK15,769
2023-11-30 2023-11-27 B Purchase
Liselotte Theorell

Other member of the company's administrative, management or supervisory body
927,581
0.02
SEK15,769 		927,581 0.02 SEK15,769
2023-11-30 2023-11-27 B Purchase
Camilla Wennersten

Other member of the company's administrative, management or supervisory body
927,581
0.02
SEK15,769 		927,581 0.02 SEK15,769
2023-11-30 2023-11-27 B Purchase
3.7
Gunnar Telhammar

Chief Financial Officer (CFO)

Through BioFinans AB, a closely affiliated person Officer
927,581
0.02
SEK15,769 		927,581 0.02 SEK15,769
2023-10-30 2023-10-25 B Purchase
2.8
Evy Lundgren Åkerlund

Chief Executive Officer (CEO)/Managing Directory

Officer
13,300,465
0.02
SEK252,709 		13,300,465 0.02 SEK252,709
2023-06-30 2023-06-29 B Purchase
1.0
Maarten de Chateau

Member of the Board of Directors

Director
42,000
0.90
SEK37,800 		42,000 0.90 SEK37,800
2023-06-27 2023-06-22 B Purchase
Evy Lundgren-Åkerlund

Chief Executive Officer (CEO)/Managing Directory

Through Anders Åkerlund, a closely affiliated person Officer
192,000
0.90
SEK172,800 		192,000 0.90 SEK172,800
2023-06-22 2023-06-22 B Purchase
Peter Ekolind

Other senior executive

Through Pekoli AB, a closely affiliated person Officer
177,776
0.90
SEK159,998 		177,776 0.90 SEK159,998
2023-06-21 2023-06-20 B Purchase
3.2
DEREK BATCHELLER

Chairman of the Board of Directors

Director
839,244
0.90
SEK755,320 		839,244 0.90 SEK755,320
2023-06-20 2023-06-20 B Purchase
3.7
Gunnar Telhammar

Chief Financial Officer (CFO)

Officer
6,000
0.90
SEK5,400 		6,000 0.90 SEK5,400
Explore more

More insider trading research around Xintela AB

More insider trades in Sweden
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe